Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Neurescue’s Breakthrough Intelligent Balloon Catheter FDA 510(k) Cleared for Hemorrhage Control and IDE Approved for Cardiac Arrest
06/10/2021
Device is FDA IDE approved to start a clinical study in the U.S. to investigate a novel cardiac arrest treatment indication   COPENHAGEN, Denmark, June 10, 2021 -- Neurescue, a medical device company developing...
Device is FDA IDE approved to start a clinical study in the U.S. to investigate a novel cardiac arrest treatment indication   COPENHAGEN, Denmark, June 10, 2021 -- Neurescue, a medical device company developing...
Device is FDA IDE...
06/10/2021
Vascular Disease Management
News
HST Pathways Announces Merger with Clariti Health for Enhanced Patient Price Transparency Resources as Part of its End-to-End Premium Technology Solution
06/01/2021
The merger combines HST Pathways’ best in class revenue cycle management tool with premium solutions to address ASC patient, provider, and administrative needs NASHVILLE, TN, June 17, 2021 — HST Pathways announced its merger with...
The merger combines HST Pathways’ best in class revenue cycle management tool with premium solutions to address ASC patient, provider, and administrative needs NASHVILLE, TN, June 17, 2021 — HST Pathways announced its merger with...
The merger combines HST...
06/01/2021
Vascular Disease Management
News
Late Breaking Data at EuroPCR Demonstrates Long-Term Benefits of Medtronic Radiofrequency Renal Denervation in Real-World Hypertensive Patients
05/19/2021
DUBLIN, May 18, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced new clinical data from the Global SYMPLICITY Registry (GSR) indicating that renal denervation (RDN) with the Medtronic...
DUBLIN, May 18, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced new clinical data from the Global SYMPLICITY Registry (GSR) indicating that renal denervation (RDN) with the Medtronic...
DUBLIN, May 18,...
05/19/2021
Vascular Disease Management

Advertisement

News
Philips Announces European Availability of Innovations to Advance Personalized and Efficient Cardiac Care at EuroPCR 2021
05/19/2021
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the European availability of new innovations in its unique portfolio of solutions that integrate imaging, devices, software, informatics and services...
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the European availability of new innovations in its unique portfolio of solutions that integrate imaging, devices, software, informatics and services...
Royal Philips (NYSE: PHG, AEX:...
05/19/2021
Vascular Disease Management
News
CereMetrix Corp. Introduces Enhancements to its Advanced Medical Imaging and Analytics Platform
05/04/2021
CereMetrix 2.0 leverages the platform’s quantitative SPECT imaging and reporting capabilities to accommodate a broader range of modality agnostic clinical and research applications.
CereMetrix 2.0 leverages the platform’s quantitative SPECT imaging and reporting capabilities to accommodate a broader range of modality agnostic clinical and research applications.
CereMetrix 2.0 leverages the...
05/04/2021
Vascular Disease Management
News
Micro Medical Solutions Receives FDA Breakthrough Device Designation for MicroStent Vascular Stent
05/04/2021
Breakthrough Designation Helps Advance Treatment Options, Targeting a Significant Unmet Need in the Treatment of CLTI. Micro Medical Solutions (MMS), focused on the treatment of CLTI, today announced that the U.S. Food and Drug Administration...
Breakthrough Designation Helps Advance Treatment Options, Targeting a Significant Unmet Need in the Treatment of CLTI. Micro Medical Solutions (MMS), focused on the treatment of CLTI, today announced that the U.S. Food and Drug Administration...
Breakthrough Designation Helps...
05/04/2021
Vascular Disease Management

Advertisement

News
Cerus Endovascular Announces IDE Approval from the U.S. FDA to Conduct Clinical Study of the Contour Neurovascular System™
04/21/2021
Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application to conduct a U.S. trial...
Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application to conduct a U.S. trial...
Cerus Endovascular Ltd., a...
04/21/2021
Vascular Disease Management
News
Five-year Patient-level Meta-analysis of ILLUMENATE EU RCT and Pivotal Study Results Confirms Safety Profile of Philips Stellarex .035” Low-dose Drug-Coated Balloon
04/20/2021
Stellarex is the only Drug-Coated Balloon (DCB) to consistently demonstrate no difference in mortality every year through five years when compared with percutaneous transluminal angioplasty (PTA), the current standard of care.
Stellarex is the only Drug-Coated Balloon (DCB) to consistently demonstrate no difference in mortality every year through five years when compared with percutaneous transluminal angioplasty (PTA), the current standard of care.
Stellarex is the only...
04/20/2021
Vascular Disease Management
News
Study Shows the Use of Temporary Intravascular Shunts Improves Early Limb Salvage after Extremity Vascular Injury
04/14/2021
Rosemont, Illinois, April 14, 2021 – A multicente
Rosemont, Illinois, April 14, 2021 – A multicente
Rosemont, Illinois, April 14,...
04/14/2021
Vascular Disease Management

Advertisement

News
The Society for Vascular Surgery Partners with the Academy for Surgical Coaching to Take Wellness Support to the Next Level
04/08/2021
New customized, peer-to-peer coaching program fills gap in health and wellness intervention for vascular surgeons. The Society for Vascular Surgery (SVS) and the Academy for Surgical Coaching today announced a partnership to develop a...
New customized, peer-to-peer coaching program fills gap in health and wellness intervention for vascular surgeons. The Society for Vascular Surgery (SVS) and the Academy for Surgical Coaching today announced a partnership to develop a...
New customized, peer-to-peer...
04/08/2021
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

Sleep and CVD
Study of Sleep in Women Shows Delaying Bedtime by Just 90 Minutes Each Night Damages Endothelial Cells
08/06/2024
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of...
08/06/2024
Cath Lab Digest
Peripheral Interventions
VentureMed Completes Enrollment of the FLEX Vessel Prep System FLEX First AV Registry For The Treatment of Arteriovenous (AV) Access Management
07/30/2024
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has...
07/30/2024
Cath Lab Digest
Peripheral Interventions
Transit Scientific’s Novel XO Cath Microcatheter Breaks New Ground in Transradial Embolic Delivery Procedure
07/30/2024
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a...
07/30/2024
Cath Lab Digest
Carotid Artery Revascularization
Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
07/30/2024
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery...
07/30/2024
Cath Lab Digest
Health Care Needs
JACC: Almost Half of U.S. Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality
07/29/2024
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S....
07/29/2024
Cath Lab Digest
Renal Denervation
First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension With Ultrasound Renal Denervation
07/25/2024
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on...
07/25/2024
Cath Lab Digest
Ischemic Stroke
Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke
07/24/2024
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all...
07/24/2024
Cath Lab Digest
LINC
News
HMP Global’s Leipzig Interventional Course (LINC) Announces 20th Anniversary Congress in January 2025
07/22/2024
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier...
07/22/2024
Vascular Disease Management
News
Life Seal Vascular Inc. Awarded Prestigious NSF SBIR Grant to Advance Innovative Endovascular Aortic Aneurysm Sac Management Technology
07/17/2024
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF...
07/17/2024
Vascular Disease Management
Ischemic Stroke
Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke
07/17/2024
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the...
07/17/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use